FACTS ABOUT MBL77 REVEALED

Not all sufferers with CLL have to have therapy. Despite all latest improvements, the iwCLL however endorses watchful observation for sufferers with asymptomatic disorder.86 This recommendation relies on a minimum of two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR)